Cited by 808Air Quality and Health ImpactsCarcinogens and Genotoxicity AssessmentOccupational and environmental lung diseases

Lung adenocarcinoma promotion by air pollutants

Open access
Hill, William, Lim, Emilia L., Weeden, Clare E., Lee, Claudia, Augustine, Marcellus, Chen, Kezhong, Kuan, Feng-Che, Marongiu, Fabio +319 more·2023·Nature

Published version of a preprint

Abstract

A complete understanding of how exposure to environmental substances promotes cancer formation is lacking. More than 70 years ago, tumorigenesis was proposed to occur in a two-step process: an initiating step that induces mutations in healthy cells, followed by a promoter step that triggers cancer development1. Here we propose that environmental particulate matter measuring ≤2.5 μm (PM2.5), known to be associated with lung cancer risk, promotes lung cancer by acting on cells that harbour pre-existing oncogenic mutations in healthy lung tissue. Focusing on EGFR-driven lung cancer, which is more common in never-smokers or light smokers, we found a significant association between PM2.5 levels and the incidence of lung cancer for 32,957 EGFR-driven lung cancer cases in four within-country cohorts. Functional mouse models revealed that air pollutants cause an influx of macrophages into the lung and release of interleukin-1β. This process results in a progenitor-like cell state within EGFR mutant lung alveolar type II epithelial cells that fuels tumorigenesis. Ultradeep mutational profiling of histologically normal lung tissue from 295 individuals across 3 clinical cohorts revealed oncogenic EGFR and KRAS driver mutations in 18% and 53% of healthy tissue samples, respectively. These findings collectively support a tumour-promoting role for PM2.5 air pollutants and provide impetus for public health policy initiatives to address air pollution to reduce disease burden. Combination of epidemiology, preclinical models and ultradeep DNA profiling of clinical cohorts unpicks the inflammatory mechanism by which air pollution promotes lung cancer

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-05874-3

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [7]WHO Global Air Quality Guidelines Particulate Matter (PM2.5 and PM10), Ozone, Nitrogen Dioxide, Sulfur Dioxide and Carbon Monoxide World Health Organization 2021 34662007
  2. [39]IARC Working Group on the – Evaluation of Carcinogenic Risks to Humans IARC Monograph Diesel And Gasoline Engine Exhausts And Some Nitroarenes World Health Organization 2014 105 PMC4781216 26442290
  3. [40]IARC Working Group on the Evaluation of Carcinogenic Risks to Humans IARC Monograph Outdoor Air Pollution World Health Organization 2016 109 PMC7682275 29905447

Cited by

Sorted by citations

Authors
Hill, W., Lim, E. L., Weeden, C. E., Lee, C., Augustine, M., Chen, K., Kuan, F.-C., Marongiu, F., Evans, E. J., Moore, D. A., Rodrigues, F. S., Pich, O., Bakker, B., Cha, H., Myers, R., van Maldegem, F., Boumelha, J., Veeriah, S., Rowan, A., Naceur-Lombardelli, C., Karasaki, T., Sivakumar, M., De, S., Caswell, D. R., Nagano, A., Black, J. R. M., Martínez-Ruiz, C., Ryu, M. H., Huff, R. D., Li, S., Favé, M.-J., Magness, A., Suárez-Bonnet, A., Priestnall, S. L., Lüchtenborg, M., Lavelle, K., Pethick, J., Hardy, S., McRonald, F. E., Lin, M.-H., Troccoli, C. I., Ghosh, M., Miller, Y. E., Merrick, D. T., Keith, R. L., Al Bakir, M., Bailey, C., Hill, M. S., Saal, L. H., Chen, Y., George, A. M., Abbosh, C., Kanu, N., Lee, S.-H., McGranahan, N., Berg, C. D., Sasieni, P., Houlston, R., Turnbull, C., Lam, S., Awadalla, P., Grönroos, E., Downward, J., Jacks, T., Carlsten, C., Malanchi, I., Hackshaw, A., Litchfield, K., TRACERx Consortium, Lester, J. F., Bajaj, A., Nakas, A., Sodha-Ramdeen, A., Ang, K., Tufail, M., Chowdhry, M. F., Scotland, M., Boyles, R., Rathinam, S., Wilson, C., Marrone, D., Dulloo, S., Fennell, D. A., Matharu, G., Shaw, J. A., Riley, J., Primrose, L., Boleti, E., Cheyne, H., Khalil, M., Richardson, S., Cruickshank, T., Price, G., Kerr, K. M., Benafif, S., Gilbert, K., Naidu, B., Patel, A. J., Osman, A., Lacson, C., Langman, G., Shackleford, H., Djearaman, M., Kadiri, S., Middleton, G., Leek, A., Hodgkinson, J. D., Totten, N., Montero, A., Smith, E., Fontaine, E., Granato, F., Doran, H., Novasio, J., Rammohan, K., Joseph, L., Bishop, P., Shah, R., Moss, S., Joshi, V., Crosbie, P., Gomes, F., Brown, K., Carter, M., Chaturvedi, A., Priest, L., Oliveira, P., Lindsay, C. R., Blackhall, F. H., Krebs, M. G., Summers, Y., Clipson, A., Tugwood, J., Kerr, A., Rothwell, D. G., Kilgour, E., Dive, C., Aerts, H. J. W. L., Schwarz, R. F., Kaufmann, T. L., Wilson, G. A., Rosenthal, R., Van Loo, P., Birkbak, N. J., Szallasi, Z., Kisistok, J., Sokac, M., Salgado, R., Diossy, M., Demeulemeester, J., Bunkum, A., Stewart, A., Frankell, A. M., Karamani, A., Toncheva, A., Huebner, A., Chain, B., Campbell, B. B., Castignani, C., Puttick, C., Richard, C., Hiley, C. T., Pearce, D. R., Karagianni, D., Biswas, D., Levi, D., Hoxha, E., Cadieux, E. L., Colliver, E., Nye, E., Gálvez-Cancino, F., Athanasopoulou, F., Gimeno-Valiente, F., Kassiotis, G., Stavrou, G., Mastrokalos, G., Zhai, H., Lowe, H. L., Matos, I. G., Goldman, J., Reading, J. L., Herrero, J., Rane, J. K., Nicod, J., Lam, J. M., Hartley, J. A., Peggs, K. S., Enfield, K. S. S., Selvaraju, K., Thol, K., Ng, K. W., Dijkstra, K., Grigoriadis, K., Thakkar, K., Ensell, L., Shah, M., Duran, M. V., Litovchenko, M., Sunderland, M. W., Dietzen, M., Leung, M., Escudero, M., Angelova, M., Tanić, M., Chervova, O., Lucas, O., Al-Sawaf, O., Prymas, P., Hobson, P., Pawlik, P., Stone, R. K., Bentham, R., Hynds, R. E., Vendramin, R., Saghafinia, S., López, S., Gamble, S., Ung, S. K. A., Quezada, S. A., Vanloo, S., Zaccaria, S., Hessey, S., Ward, S., Boeing, S., Beck, S., Bola, S. K., Denner, T., Marafioti, T., Mourikis, T. P., Watkins, T. B. K., Spanswick, V., Barbè, V., Lu, W.-T., Liu, W. K., Wu, Y., Naito, Y., Ramsden, Z., Veiga, C., Royle, G., Collins-Fekete, C.-A., Fraioli, F., Ashford, P., Clark, T., Forster, M. D., Lee, S. M., Borg, E., Falzon, M., Papadatos-Pastos, D., Wilson, J., Ahmad, T., Procter, A. J., Ahmed, A., Taylor, M. N., Nair, A., Lawrence, D., Patrini, D., Navani, N., Thakrar, R. M., Janes, S. M., Hoogenboom, E. M., Monk, F., Holding, J. W., Choudhary, J., Bhakhri, K., Scarci, M., Hayward, M., Panagiotopoulos, N., Gorman, P., Khiroya, R., Stephens, R. C. M., Wong, Y. N. S., Bandula, S., Sharp, A., Smith, S., Gower, N., Dhanda, H. K., Chan, K., Pilotti, C., Leslie, R., Grapa, A., Zhang, H., AbdulJabbar, K., Pan, X., Yuan, Y., Chuter, D., MacKenzie, M., Chee, S., Alzetani, A., Cave, J., Scarlett, L., Richards, J., Ingram, P., Austin, S., Lim, E., De Sousa, P., Jordan, S., Rice, A., Raubenheimer, H., Bhayani, H., Ambrose, L., Devaraj, A., Chavan, H., Begum, S., Buderi, S. I., Kaniu, D., Malima, M., Booth, S., Nicholson, A. G., Fernandes, N., Shah, P., Proli, C., Hewish, M., Danson, S., Shackcloth, M. J., Robinson, L., Russell, P., Blyth, K. G., Dick, C., Le Quesne, J., Kirk, A., Asif, M., Bilancia, R., Kostoulas, N., Thomas, M., DeGregori, J., Jamal-Hanjani, M., & Swanton, C.
Affiliations
  • The Francis Crick Institute (GB)
  • Peking University People's Hospital (CN)
  • Chang Gung University (TW)
  • University of Cagliari (IT)
  • University of Colorado Anschutz (US)
  • University College Hospital (GB)
  • Samsung Medical Center (KR)
  • University of British Columbia (CA)
  • University College London (GB)
  • Cancer Research UK (GB)
  • Ontario Institute for Cancer Research (CA)
  • Royal Veterinary College (GB)
  • King's College London (GB)
  • NHS England (GB)
  • Chang Gung Memorial Hospital (TW)
  • VA Eastern Colorado Health Care System (US)
  • Lund University (SE)
  • Institute of Cancer Research (GB)
  • Koch Institute for Integrative Cancer Research At MIT (US)
  • Swansea Bay University Health Board (GB)
  • University Hospitals of Leicester NHS Trust (GB)
  • University of Leicester (GB)
  • Royal Free London NHS Foundation Trust (GB)
  • Aberdeen Royal Infirmary (GB)
  • University of Aberdeen (GB)
  • Whittington Hospital (GB)
  • University of Birmingham (GB)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • Cancer Research UK Manchester Centre (GB)
  • Manchester University NHS Foundation Trust (GB)
  • University of Manchester (GB)
  • The Christie NHS Foundation Trust (GB)
  • Brigham and Women's Hospital (US)
  • University of Cologne (DE)
  • Max Delbrück Center (DE)
  • Aarhus University (DK)
  • Peter MacCallum Cancer Centre (AU)
  • The Netherlands Cancer Institute (NL)
  • Institute of Structural and Molecular Biology (GB)
  • The University of Texas MD Anderson Cancer Center (US)
  • University Hospital Southampton NHS Foundation Trust (GB)
  • Guy's and St Thomas' NHS Foundation Trust (GB)
  • Royal Surrey County Hospital (GB)
  • Sheffield Teaching Hospitals NHS Foundation Trust (GB)
  • Liverpool Heart and Chest Hospital (GB)
  • Princess Alexandra Hospital NHS Trust (GB)
  • Cancer Research UK Scotland Institute (GB)
  • NHS Greater Glasgow and Clyde (GB)
  • Golden Jubilee National Hospital (GB)
Corresponding author
Swanton, Charles
ORCID
Venue
Nature
Published
2023-04-05
Volume
616
Issue
7955
Pages
159-167
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4362606390
Cited by
808
References
81
Citations by year
2026: 194 · 2025: 264 · 2024: 248 · 2023: 100 · 2022: 1
FWCI
92.48
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • Pure Amsterdam UMC (publishedVersion, cc-by)
  • Research Explorer (The University of Manchester) (publishedVersion, other-oa)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion, cc-by)
  • Queen Mary Research Online (Queen Mary University of London) (acceptedVersion, cc-by)
  • PubMed Central (acceptedVersion, cc-by)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion, cc-by)
  • UCL Discovery (University College London) (submittedVersion, cc-by)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, cc-by)
  • Lirias (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Lund University Publications (Lund University) (submittedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • American Association for Cancer Research (SU2C-AACR-DT23-17, 18-90-52-DEGR)
  • U.S. Department of Veterans Affairs (I01 BX004495)
  • Breast Cancer Research Foundation (SU2C-AACR-DT23-17)
  • LUNGevity Foundation (SU2C-AACR-DT23-17)
  • Amgen
  • Bristol-Myers Squibb
  • Pfizer
  • AstraZeneca
  • International Association for the Study of Lung Cancer
  • Entertainment Industry Foundation
  • European Respiratory Society
  • Wellcome Trust (FP7/2007–2013, FC001169, 100034, 16584, CC2041, FC001112, 211179/Z/18/Z, 211179, 103799/A/14/Z)
  • Francis Crick Institute (CC2088, FC001112, CC1064, CC2008, CC1119, CC2097, CC1061, FC001169, CC1062, CC2051, CC2041)
  • LifeArc
  • Génome Québec
  • Astex Pharmaceuticals
  • Revolution Medicines
  • Invitae
  • Cancer Research UK (FP7/2007-2013, 25349, 25514, EDDPJT-Nov22/100042, CTRNBC-2022/100001, EDDPMA‐Nov21/100034, ID16584, SEBSTF-2021\100007, 16584, 21999, 17786, CC2041, RCCFEL\100099, FC001169, C69256/A30194, 29569, 30025, FC001112)
  • National Institute for Health and Care Research (FP7/2007–2013, CL-2020-18-501, CL-2015-18-009, ACF-2014-18-006)
  • Royal Society (211179/Z/18/Z, 211179, RP/EA/180007)
  • University College London
  • European Commission (665233, 2007–2013, FP7 2007-2013, HORIZON2020, H2020, FP7/2007, 607722, 835297)
  • Rosetrees Trust (FP7/2007-2013, PGL21 10119, ID16584, M35-F2, A2437, OoR2020 100009)
  • National Research Foundation
  • National Natural Science Foundation of China (No.82072566, FP7/2007-2013, FP7/2007, 82072566)
  • Cancerfonden
  • Korea Health Industry Development Institute (HR20C0025)
  • National Research Foundation of Korea (HR20C0025, 2020R1A2C3006535)
  • Vetenskapsrådet (FP7/2007-2013)
  • Chang Gung Medical Foundation
  • Chinese Academy of Medical Sciences (2021RU002)
  • Peking University (RS2019-01)
  • University College London Hospitals NHS Foundation Trust
  • Ono Pharmaceutical
  • Ministry of Science and ICT, South Korea (HR20C0025)
  • Peking University People's Hospital (RS2019-01)
  • National Institutes of Health (FP7/2007-2013, H2020, P 30CA046934)
  • Genentech
  • Stand Up To Cancer (SU2C-AACRDT23-17, AACR-DT23-17)
  • Horizon 2020 Framework Programme (FP7/2007-2013, 665233, 835297)
  • Medical Research Council (FP7/20072013, MR/P014712/1, MR/V033077/1, FC001112, MR/W025051/1, MC_PC_17228, FC001169)
  • Engineering and Physical Sciences Research Council (EP/X030059/1)
  • Japan Society for the Promotion of Science (202060447, 052004)
  • National Human Genome Research Institute
  • National Cancer Institute (T32CA174648, CA190216, R01CA219893, P30CA046934, T32CA190216)
  • H2020 European Research Council (725492)
  • FP7 Ideas: European Research Council (617844)
  • Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Anschutz Medical Campus
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Air Quality and Health Impacts
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
lung adenocarcinoma, PM2.5, air pollution, tumor promotion, EGFR mutation, KRAS mutation, alveolar type II cells, macrophage infiltration, IL-1β, lung inflammation, never smokers, environmental carcinogenesis
MeSH terms
Adenocarcinoma of Lung, Air Pollutants, Air Pollution, Animals, Cell Transformation, Neoplastic, Environmental Exposure, Lung Neoplasms, Particle Size, Cohort Studies, Macrophages, Alveolar, Mice, Particulate Matter, Interleukin-1beta, Alveolar Epithelial Cells, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review